Background illustration for clinical trials search

Paid Clinical Trials Olathe

Discover 707 paid clinical trials in Olathe, Kansas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

A Study to Test the Efficacy and Safety of Riliprubart Against the Usual Treatment of Intravenous Immunoglobulin (IVIg) in People With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

for
Chronic Inflammatory Demyelinating Polyneuropathy
Location: Kansas City KS, St Louis MO, Miami Lakes FL,
Sponsor: Sanofi

Sex: All

Age: 18+

Code: NCT06290141

Phase3, Recruiting

Linking Novel Diagnostics With Data-Driven Clinical Decision Support in the Emergency Department

for
Inpatient Hospitalization, Intensive Care Unit Admission, Inpatient Mortality, Sepsis and Septic Shock,
Location: Kansas City KS, Kansas City MO
Sponsor: Stocastic, LLC

Sex: All

Age: 18+

Code: NCT05335135

Recruiting

Prebiotic Galacto-oligosaccharide and Acute GVHD

for
Acute GVHD
Location: Kansas City KS
Sponsor: University of Kansas Medical Center

Sex: All

Age: 18 - 70+

Code: NCT04373057

Phase1, Phase2, Recruiting

A Study to Learn About the Treatment LTP001 in Healthy Participants (Part A) and in Participants With PAH (Part B)

for
Healthy Volunteers, Pulmonary Arterial Hypertension
Location: Kansas City KS, Dallas TX, Louisville KY, Ridgeland MS,
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 18 - 70+

Code: NCT06649110

Phase1, Phase2, Recruiting

Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype

for
Chronic Obstructive Pulmonary Disease
Location: Kansas City KS, Chickasha OK, Rochester MN, Allen TX,
Sponsor: Sanofi

Sex: All

Age: 40 - 70+

Code: NCT07190209

Phase3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Study to Investigate Airway Inflammation With Dupilumab Subcutaneously in Participants Aged ≥40 to ≤85 Years With Chronic Obstructive Pulmonary Disease.

for
Chronic Obstructive Pulmonary Disease
Location: Kansas City KS, Birmingham AL, Beaumont TX, London,
Sponsor: Sanofi

Sex: All

Age: 40 - 70+

Code: NCT07053423

Recruiting

An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease

for
Crohn's Disease
Location: Kansas City KS, Liberty MO, Clive IA, St Louis MO,
Sponsor: Sanofi

Sex: All

Age: 16 - 70+

Code: NCT07184931

Phase3, Recruiting

Pompe Disease Registry Protocol

for
Glycogen Storage Disease Type II, Pompe Disease
Location: Kansas City KS, Columbia MO, Omaha NE, St Louis MO,
Sponsor: Genzyme, a Sanofi Company

Sex: All

Age: 0+

Code: NCT00231400

Recruiting

Fabry Disease Registry & Pregnancy Sub-registry

for
Fabry Disease
Location: Kansas City KS, Columbia MO, Omaha NE, St Louis MO,
Sponsor: Genzyme, a Sanofi Company

Sex: All

Age: 0+

Code: NCT00196742

Recruiting
New

Motor-Cognitive Training for Motoric Cognitive Risk Syndrome

for
Motoric Cognitive Risk Syndrome
Location: Kansas City KS
Sponsor: University of Kansas Medical Center

Sex: All

Age: 65+

Code: NCT07223905

Recruiting

Catamenial Epilepsy Treatment

for
Epilepsy
Location: Kansas City KS
Sponsor: Timothy Welty, PharmD

Sex: Female

Age: 21 - 45

Code: NCT01299870

Phase2, Recruiting

Aerobic Walking Exercise for Non-Ambulatory Stroke Survivors

for
Stroke
Location: Kansas City KS
Sponsor: University of Kansas Medical Center

Sex: All

Age: 18+

Code: NCT03479632

Recruiting

Platform Clinical Study for Conquering Scleroderma

for
Interstitial Lung Disease Due to Systemic Disease, Scleroderma
Location: Kansas City KS, Rochester MN, Chicago IL, Milwaukee WI,
Sponsor: Scleroderma Research Foundation, Inc.

Sex: All

Age: 18+

Code: NCT06195072

Phase2, Recruiting

Sinus Disease in Young Children With Cystic Fibrosis

for
Cystic Fibrosis in Children, Cystic Fibrosis,
Location: Kansas City KS, Iowa City IA, Aurora CO, Cincinnati OH,
Sponsor: University of California, Los Angeles

Sex: All

Age: 2 - 8

Code: NCT06191640

Recruiting

Gestational Response, Outcomes, and Weight After GLP-1 Use

for
Pregnant Individuals, Obesity & Overweight,
Location: Kansas City KS
Sponsor: University of Kansas Medical Center

Sex: Female

Age: 18 - 45

Code: NCT07743567

Recruiting

A Study to Investigate the Efficacy and Safety of Frexalimab Versus Tacrolimus in Adults Undergoing Kidney Transplantation

for
Kidney Transplant Rejection
Location: Kansas City KS, Hines IL, Ann Arbor MI, Columbus OH,
Sponsor: Sanofi

Sex: All

Age: 18 - 70

Code: NCT07412470

Phase2, Phase3, Recruiting

An Adaptive Program of IKT-001 in Pulmonary Arterial Hypertension (PAH)

for
Pulmonary Arterial Hypertension
Location: Kansas City KS, St Louis MO, Dallas TX, Nashville TN,
Sponsor: Inhibikase Therapeutics

Sex: All

Age: 18 - 70+

Code: NCT07365332

Phase3, Recruiting

Assessing the Association Between WBCT PFJ Morphological Metrics and Knee Symptoms

for
Knee Osteoarthritis, Patellofemoral Pain (PFPS)
Location: Kansas City KS
Sponsor: University of Kansas Medical Center

Sex: All

Age: 18+

Code: NCT07472088

Recruiting

Prospective Randomized Observer Blinded Single Center Study Comparing 90-day Functional Outcome in Patients Who Received Intravenous Propofol Infusion Versus Inhalational Sevoflurane for General Anesthesia During Mechanical Thrombectomy in Patients Who Suffered From Acute Ischemic Stroke

for
Acute Ischemic Stroke Patients
Location: Kansas City KS
Sponsor: University of Kansas Medical Center

Sex: All

Age: 18+

Code: NCT07001267

Recruiting

An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis

for
Ulcerative Colitis
Location: Kansas City KS, Liberty MO, Clive IA, Chesterfield MO,
Sponsor: Sanofi

Sex: All

Age: 16 - 70+

Code: NCT07184996

Phase3, Recruiting